Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12623000853640
ACTRN12623000853640
Recruiting
未知

Exploring Predictive and Prognostic Biomarkers in People with Cancer.

Monash Health0 sites500 target enrollmentAugust 8, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCancerCancer - Any cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
Cancer
Sponsor
Monash Health
Enrollment
500
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 8, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Monash Health patients will be included in this study if they meet all of the following inclusion criteria:
  • •1\. Aged 18 years or older
  • •2\. Histological or cytological diagnosis of solid organ cancer
  • •3\. Able to be accessible for follow\-up and data collection
  • •4\. Able to provide written, voluntary and informed consent
  • •5\. Able to undergo core needle biopsy of metastases (patients must have a lesion which is deemed medically safe to biopsy as part of routine standard of care)
  • •6\. Able to undergo collection of blood specimens during treatment. ; Monash Health patients will be included in this study if they meet all of the following inclusion criteria:
  • •1\. Aged 18 years or older
  • •2\. Histological or cytological diagnosis of solid organ cancer
  • •3\. Able to be accessible for follow\-up and data collection

Exclusion Criteria

  • •Monash Health patients will be excluded from this study if they meet any of the following exclusion criteria:
  • •1\. Unable to be accessible for follow\-up and data collection
  • •2\. Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the protocol.
  • •; Monash Health patients will be excluded from this study if they meet any of the following exclusion criteria:
  • •1\. Unable to be accessible for follow\-up and data collection
  • •2\. Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the protocol.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Identifying and validating predictive and prognostic biomarkers in male Germ Cell Tumours to improve the management and outcomes in both stage 1 and disseminated disease.Germ Cell Tumour (GCT)SeminomaTesticular cancerCancer - Testicular
ACTRN12618000931279Walter and Eliza Hall Institute for Medical Research800
Not yet recruiting
Not Applicable
Biomarkers in Pancreatic CancerHistologically or cytologically confirmed pancreatic cancerCancer - Pancreatic
ACTRN12616000519459The Walter and Eliza Hall Institute of Medical Research500
Recruiting
Not Applicable
Exploratory analysis of biomarkers predicting the treatment response and the prognosis in patients with gastric carcinoma
JPRN-UMIN000036886Sapporo Medical University350
Recruiting
Not Applicable
Exploratory analysis of biomarkers predicting the treatment response and the prognosis in patients with esophageal carcinomaEsophageal cancer
JPRN-UMIN000036884Department of Medical Oncology, Sapporo Medical University School of Medicine250
Recruiting
Not Applicable
Exploratory analysis of biomarkers predicting the treatment response and the prognosis in patients with colorectal carcinomaColorectal cancer Colon cancer Rectal cancer
JPRN-UMIN000036891Department of Medical Oncology, Sapporo Medical University School of Medicine350